Low-dose clofarabine in combination with a standard remission induction in patients aged 18–60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: combined phase I/II results of the EORTC/GIMEMA AML-14A trial

Guardado en:
Detalles Bibliográficos
Publicado en:Haematologica
Autores principales: Selleslag, Dominik, Suciu, Stefan, Meloni, Giovanna, Muus, Petra, Halkes, Constantijn J.M., Venditti, Adriano, Ramadan, Safaa M., Pruijt, Hans, Meert, Liv, Vignetti, Marco, Marie, Jean-Pierre, Wittnebel, Sébastian, de Witte, Theo, Amadori, Sergio, Willemze, Roelof, Baron, Frédéric
Formato: Artigo
Lenguaje:Inglês
Publicado: Ferrata Storti Foundation 2017
Materias:
Online Only Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5286953/
https://ncbi.nlm.nih.gov/pubmed/27789677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2016.153130
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares